Recent Updates
Recently added Catalysts
USNA Positive Sentiment

USANA Schedules Third Quarter 2026 Earnings Release and Conference Call

Monday, October 12, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: USANA Health Sciences, Inc. has announced the release date for its third quarter 2026 earnings, which will occur after market close on November 3, 2026. Following the earnings release, a Management Commentary document will be available on the company's Investor Relations website. Additionally, a conference call will be held to discuss the results with analysts.

Market Sentiment Analysis

POSITIVE FACTORS

  • USANA is proactively communicating its earnings schedule.
  • The company is engaging with analysts through a conference call.
  • Management Commentary will be available for investors.

Full Press Release Details

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2026 results will be released after the close of market on Tuesday, November 3, 2026. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and insti

Frequently Asked Questions

When will USANA release its Q3 2026 earnings?

USANA will release its third quarter 2026 earnings on November 3, 2026.

Where can I find USANA's Management Commentary?

The Management Commentary will be posted on USANA's Investor Relations website.

Will there be a conference call for USANA's earnings?

Yes, USANA will hold a conference call to discuss the earnings announcement.

What time will USANA's earnings be released?

The earnings will be released after the market closes on November 3, 2026.

ShareAdd on Google
Tags: USNA USANA earnings release conference call Investor Relations
Last updated: Oct 12, 2026

Biotech snapshot

Cash runway
$169M liquidity · $0M/mo burn
Low dilution risk